Industry News

Beckman Coulter to Acquire Siemens Healthcare Diagnostics’ Clinical Microbiology Business

Published on

Beckman Coulter, a subsidiary of Danaher Corp, has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics.

The Siemens clinical microbiology business is an established leader in microbial identification and antibiotic sensitivity testing (ID/AST), and operates with an installed base of more than 6,000 instruments globally. The microbiology product line includes MicroScan brand instruments, panels, and consumables, along with data management solutions. MicroScan systems are recognized in the industry for their high accuracy and superior detection of emerging resistance.


Arnd Kaldowski

“The clinical microbiology business will be an excellent complement to Beckman Coulter’s Diagnostics business, with a strong reputation and market position,” said Arnd Kaldowski, president of Beckman Coulter Diagnostics. “Adding its ID/AST solutions to our existing products and services will create an opportunity to enhance our offerings to laboratory customers and improve patient care. The acquisition expands our product portfolio with differentiated analytical systems and menus that elevate our clinical capabilities for customers, while driving continued growth.”

The transaction is expected to close in the first quarter of 2015, subject to applicable regulatory approvals and other customary closing conditions.

For more information, visit Beckman Coulter.